Category
February 22, 2019
Ewing sarcoma research Yuzuru Shiio, MD, PhD, of the Greehey Children’s Cancer Research Institute at UT Health San Antonio, was awarded $1.2 million to further studies of Ewing sarcoma, a pediatric bone and soft tissue cancer. The median age of Ewing sarcoma patients is 15 years, and more than half of patients are adolescents. Dr. […]
February 7, 2019
Expert pediatric cancer physicians and researchers at UT Health San Antonio are working to improve the lives of children with cancer, both for today and tomorrow. UT Health San Antonio, in partnership with the University Health System, offers advanced care for children battling cancer through the South Texas Pediatric Blood and Cancer Center. The team, […]
February 6, 2019
By studying the outcomes of more than 28,000 long-term childhood cancer survivors in the United States and Europe, researchers found that exposure to different anthracyclines results in variable long-term cardiovascular risk.
January 31, 2019
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with the development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment.
January 31, 2019
Gregory Aune, MD, PhD, of UT Health San Antonio, served on a team that found different chemotherapy drugs used to treat children with cancer appear to have different risks long term for cardiomyopathy (abnormal heart muscle with impaired function). The study was in more than 28,000 childhood cancer survivors. Credit: UT Health San Antonio In […]
January 31, 2019
Study of 28,000 childhood cancer survivors finds important differences In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with the development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment.
January 21, 2019
SAN ANTONIO — In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs with the development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment.
December 21, 2018
Hung-I Harry Chen, Yu-Chiao Chiu, Tinghe Zhang, Songyao Zhang, Yufei Huang & Yidong Chen Abstract Background Bioinformatics tools have been developed to interpret gene expression data at the gene set level, and these gene set-based analyses improve the biologists’ capability to discover the functional relevance of their experiment design. While elucidating gene set individually, inter-gene sets association is rarely taken into […]
December 14, 2018
https://www.youtube.com/watch?v=PCMFvlYPBfMDecember 12, 2018
UT Health San Antonio MD Anderson Cancer Center’s mission is to conquer cancer through research, prevention, and treatment—while offering world-class care close to home for patients in South Texas. How do ideas, collaboration, and dedication turn into hope for cancer patients? We’re how. You’re why. For more information about UT Health San Antonio, MD Anderson […]